Search

everythinglearnresearchcommunity

for

Search:↓

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Auto-portraits help evaluate scalp hair.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Flutamide reduces hair growth better but has more side effects.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Finasteride safely reduces excessive hair growth in women.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

AGA patients have higher heart disease risk.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.